why choose us

First received: May 29, 2023

Clinical Trial: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Alzheimers Disease

Study Type: INTERVENTIONAL


Official Title: A Randomised Double-blind Placebo-controlled Clinical Study Investigating the Effects of Semaglutide s.c. Once-weekly Versus Placebo on Central and Peripheral Inflammation in Participants With Alzheim

Brief Summary: The study is being conducted to understand how the medicine, semaglutide, affects the immune system and other biological processes in people with Alzheimer's disease.Semaglutide is a medicine that doctors can prescribe in some countries for the treatment of type 2 diabetes and excess body weight.This study will help us understand whether semaglutide can also be used for the treatment of Alzheimer's disease.The study will last for about 77 weeks.In the first 12 weeks of treatment, participants will either…

Read more